Intervention not reported
Severity of depression continuous measures ‐ HDRS total score at the end of the treatment: Tricyclics versus placebo · patients with depression during opioid agonist treatment for opioid dependence
1 finding from 1 review
Intervention not reported
Adverse events ‐ Withdrawn for medical reasons: Tricyclics versus placebo · patients with depression during opioid agonist treatment for opioid dependence
The intervention leads to higher adverse events ‐ Withdrawn for medical reasons: Tricyclics versus… (high certainty).
1 finding from 1 review
Intervention not reported
Anthropometric outcomes ‐ not reported · patients with HIV infection or exposure
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Muscle strength Isometric extension · patients with patients with Rheumatoid Arthritis
1 finding from 1 review
Intervention not reported
Muscle strength Isometric extension · patients with Rheumatoid Arthritis
1 finding from 1 review
Intervention not reported
Muscle strength Isometric extension · patients with Rheumatoid Arthritis
1 finding from 1 review
Intervention not reported
Childrens anthropometric outcomes
The intervention probably leads to lower childrens anthropometric outcomes (moderate certainty).
1 finding from 1 review
no estimate extracted
Studies not reported
Moderate
Empirical antifungal treatment · Patients with cancer receiving chemotherapy and/or radiotherapy
Itraconazole showed no clear difference in empirical antifungal treatment compared with fluconazole; GRADE not reported.
1 finding from 1 review
Empirical antifungal treatment · Patients with cancer receiving chemotherapy and/or radiotherapy
Antifungal drugs absorbed from GI tract (fluconazole, ketoconazole,… led to lower empirical antifungal treatment compared with placebo or no treatment; GRADE not reported.
1 finding from 1 review
Empirical antifungal treatment · Patients with cancer receiving chemotherapy and/or radiotherapy
Antifungal drugs absorbed from GI tract showed no clear difference in empirical antifungal treatment compared with antifungal drugs not absorbed from GI tract; GRADE not reported.
1 finding from 1 review
Empirical antifungal treatment · Patients with cancer receiving chemotherapy and/or radiotherapy
Antifungal drugs partially absorbed from GI tract (miconazole,… showed no clear difference in empirical antifungal treatment compared with placebo or no treatment; GRADE not reported.
1 finding from 1 review
Change in maximal isometric voluntary contraction force (Nm) · patients with people with peripheral neuropathy
1 finding from 1 review
Muscle strength · patients with the treatment of amyotrophic lateral sclerosis or motor neuron disease
1 finding from 1 review
Mortality (at the end of · adults receiving EN via nasogastric or gastrostomy tube
It is very uncertain whether more frequent (less than eight hours) changes mortality (at the end of compared with less frequent (eight hours or greater) monitoring of gastric… (very low certainty).
1 finding from 1 review
Mortality (at the end of · adults receiving EN via nasogastric or gastrostomy tube
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Pneumonia · adults receiving EN via nasogastric or gastrostomy tube
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Length of hospital stay · adults receiving EN via nasogastric or gastrostomy tube
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Pneumonia · adults receiving EN via nasogastric or gastrostomy tube
It is very uncertain whether more frequent (less than eight hours) changes pneumonia (until discontinued or up to 28 days) compared with less frequent (eight hours or greater) monitoring of gastric… (very low certainty).
1 finding from 1 review
Length of hospital stay · adults receiving EN via nasogastric or gastrostomy tube
1 finding from 1 review
Mortality (at the end of · adults receiving EN via nasogastric or gastrostomy tube
It is very uncertain whether no monitoring changes mortality (at the end of compared with frequent monitoring (12 hours or less) of gastric residual volume (very low certainty).
1 finding from 1 review